Table 1. Number of tumor-specific and germline mt variants with corresponding differences and coefficients.
Patient | Tumor-specific mt variants (n)a | Differenceb | Germline mt variants (n)c | Coefficientd | ||
---|---|---|---|---|---|---|
P | R | P | R | |||
1 | 10 | 4 | −6 | 187 | 51 | −175.5 |
2 | 0 | 16 | 16 | 5 | 66 | −62.0 |
3 | 4 | 19 | 15 | 191 | 30 | −6.0 |
4 | 0 | 19 | 19 | 10 | 160 | 40.5 |
5 | 4 | 19 | 15 | 265 | 223 | −64.0 |
6 | 0 | 0 | 0 | 219 | 110 | −23.5 |
7 | 0 | 21 | 21 | 3 | 84 | −1.0 |
8 | 0 | 6 | 6 | 36 | 115 | 40.5 |
9 | 9 | 10 | 1 | 277 | 231 | 12.5 |
10 | 0 | 0 | 0 | 55 | 59 | −110.0 |
11 | 2 | 12 | 10 | 3 | 62 | −32.5 |
12 | 2 | 2 | 0 | 51 | 49 | −138.5 |
13 | 12 | 14 | 2 | 219 | 113 | 15.0 |
14 | 0 | 1 | 1 | 1 | 2 | −3.0 |
15 | 3 | 4 | 1 | 350 | 172 | −135.5 |
16 | 2 | 6 | 4 | 141 | 55 | −74.5 |
Number of tumor-specific mt variants: P, primary tumor; R, relapse tumor. Variants with an allele frequency of at least 1% were analyzed.
Difference: Pairwise difference between primary and relapse tumor.
Number of germline mt variants: P, primary tumor; R, relapse tumor. Variants with an allele frequency of at least 1% were analyzed.
Coefficient: Coefficient as calculated by linear regression.